55-60 a-INTERFERON AS MAINTENANCE DRUG AFTER INITIAL FLUDARABINE THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND LOW-GRADE NON-HODGKIN’S LYMPHOMA Pier Luigi Zinzani, Mario Giulio Levrero, Francesco Lauria, Damiano Rondelli, Francesco Zaja, Domenico Russo, Renato Fanin, Giulio De Rossi, Francesca Romana Mauro, Maurizio Bendandi, Alessandro Gozzetti, Ferdinando Dianzani, Franco Mandell...

Title: Isorhamnetin 3-O-robinobioside from Nitraria retusa leaves enhance antioxidant and antigenotoxic activity in human chronic myelogenous leukemia cell line K562

Objective: To observe the K562 cell line derived from a patient of chronic myelogenous leukemia differentiated into megakaryocytes by growing in the presence of phorbol myristate

chronic myelogenous leukemia (cml) is a stem cell disorder sometimes associated with lymphoproliferative disorders. cml may precede a lymphoproliferative disorder. there are a few reports showing associating of cml with multiple myeloma and we report a known cml case that transformed into a full-blown multiple myeloma. this patient had more than 69% of infiltrating myeloma cells in her bone mar...